Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 299321 - 299340 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Latvia | (L01DB01) doxorubicin | Myocet liposomal | 2 Pulveris, dispersija un šķīdinātājs infūziju dispersijas koncentrāta pagatavošanai, 50 mg | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | CheplapharmArzneimittelGmbH,Germany / GP-PHARMS.A.,Spain |
| Latvia | (L01DB03) epirubicin | Epirubicin Accord 2 mg/ml šķīdums injekcijām vai infūzijām | 1 Šķīdums injekcijām/infūzijām, 2 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V.,Netherlands / LaboratoriFundacioDau,Spain;AccordHealthcarePolskaSp.z.o.o.,Poland;AccordHealthcareSingleMemberS.A.,Greece |
| Latvia | (L01DB03) epirubicin | Epirubicin Accord 2 mg/ml šķīdums injekcijām vai infūzijām | 1 Šķīdums injekcijām/infūzijām, 2 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V.,Netherlands / LaboratoriFundacioDau,Spain;AccordHealthcarePolskaSp.z.o.o.,Poland;AccordHealthcareSingleMemberS.A.,Greece |
| Latvia | (L01DB06) idarubicin | Zavedos 10 mg pulveris injekciju šķīduma pagatavošanai | 1 Pulveris injekciju šķīduma pagatavošanai, 10 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | PfizerEuropeMAEEIG,Belgium / LatinaPharmaS.p.A.,Italy |
| Latvia | (L01DB06) idarubicin | Zavedos 5 mg pulveris injekciju šķīduma pagatavošanai | 1 Pulveris injekciju šķīduma pagatavošanai, 5 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | PfizerEuropeMAEEIG,Belgium / LatinaPharmaS.p.A.,Italy |
| Latvia | (L01DC01) bleomycin | Bleomycin medac 15000 SV pulveris injekciju šķīduma pagatav | 1 Pulveris injekciju šķīduma pagatavošanai, 15000 SV | Retail price with vat |
$0-0 |
$0-0 |
n/a | MedacGesellschaftfürklinischeSpezialpräparatembH,Germany / MedacGesellschaftfürklinischeSpezialpräparatembH,Germany |
| Latvia | (L01DC03) mitomycin | Mitomycin medac 1 mg/ml pulveris injekciju/infūziju šķīduma | 10 Pulveris injekciju/infūziju šķīduma pagatavošanai vai intravezikāli lietojama šķīduma pagatavošanai, 1 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | MedacGesellschaftfürklinischeSpezialpräparatembH,Germany / MedacGesellschaftfürklinischeSpezialpräparatembH,Germany |
| Latvia | (L01DC03) mitomycin | Mitomycin medac 1 mg/ml pulveris injekciju/infūziju šķīduma | 1 Pulveris injekciju/infūziju šķīduma pagatavošanai vai intravezikāli lietojama šķīduma pagatavošanai, 1 mg/ml | Retail price with vat |
$0-0 |
$0-0 |
n/a | MedacGesellschaftfürklinischeSpezialpräparatembH,Germany / MedacGesellschaftfürklinischeSpezialpräparatembH,Germany |
| Latvia | (L01DC03) mitomycin | Mitomycin medac 40 mg pulveris un šķīdinātājs intravezikāli | 1 Pulveris un šķīdinātājs intravezikāli lietojama šķīduma pagatavošanai, 40 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | MedacGesellschaftfürklinischeSpezialpräparatembH,Germany / MedacGesellschaftfürklinischeSpezialpräparatembH,Germany |
| Latvia | (L01EA01) imatinib (adm: O) | Glivec | 120 Kapsula, cietā, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisEuropharmLimited,Ireland / NovartisPharmaGmbH,Germany;SandozS.R.L.,Romania;Lekd.d.,PEProizvodnjaLendava,Slovenia |
| Latvia | (L01EA01) imatinib (adm: O) | Imatinib Grindeks 100 mg cietās kapsulas | 120 Kapsula, cietā, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | Grindeks,AS,Latvia / Grindeks,AS,Latvia |
| Latvia | (L01EA01) imatinib (adm: O) | Glivec | 120 Apvalkotā tablete, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisEuropharmLimited,Ireland / NovartisPharmaGmbH,Germany;SandozS.R.L.,Romania;Lekd.d.,PEProizvodnjaLendava,Slovenia |
| Latvia | (L01EA01) imatinib (adm: O) | Imatinib Accord | 120 Apvalkotā tablete, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | AccordHealthcareS.L.U.,Spain / AccordHealthcarePolskaSp.z.o.o.,Poland |
| Latvia | (L01EA01) imatinib (adm: O) | Imatinib Accord | 120 Apvalkotā tablete, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | AccordHealthcareS.L.U.,Spain / AccordHealthcarePolskaSp.z.o.o.,Poland |
| Latvia | (L01EA01) imatinib (adm: O) | Imatinib Teva | 120 Apvalkotā tablete, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Myelodysplastic-Myeloproliferative Diseases;Hypereosinophilic Syndrome;Dermatofibrosarcoma | TevaB.V.,Netherlands / TevaPharmaceuticalWorksPrivateLimitedCompany,Hungary;TevaUKLtd.,UnitedKingdom;MerckleGmbH,Germany;TEVACzechIndustriess.r.o.,CzechRepublic;TevaPharmaB.V.,Netherlands;TevaOperationsPolandSp.zo.o.,Poland;TevaPharma,S.L.U.,Spain;PlivaCroatiaLtd.,Croatia |
| Latvia | (L01EA01) imatinib (adm: O) | Imatinib Teva | 120 Apvalkotā tablete, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Myelodysplastic-Myeloproliferative Diseases;Hypereosinophilic Syndrome;Dermatofibrosarcoma | TevaB.V.,Netherlands / TevaPharmaceuticalWorksPrivateLimitedCompany,Hungary;TevaUKLtd.,UnitedKingdom;MerckleGmbH,Germany;TEVACzechIndustriess.r.o.,CzechRepublic;TevaPharmaB.V.,Netherlands;TevaOperationsPolandSp.zo.o.,Poland;TevaPharma,S.L.U.,Spain;PlivaCroatiaLtd.,Croatia |
| Latvia | (L01EA01) imatinib (adm: O) | Itivas 100 mg apvalkotās tabletes | 60 Apvalkotā tablete, 100 mg | Retail price with vat |
$0-0 |
$0-0 |
n/a | TADPharmaGmbH,Germany / KRKA,d.d.,Novomesto,Slovenia;TADPharmaGmbH,Germany;KRKA-FARMAd.o.o.,Croatia |
| Latvia | (L01EA01) imatinib (adm: O) | Glivec | 30 Apvalkotā tablete, 400 mg | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Gastrointestinal Stromal Tumors;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | NovartisEuropharmLimited,Ireland / NovartisPharmaGmbH,Germany;SandozS.R.L.,Romania;Lekd.d.,PEProizvodnjaLendava,Slovenia |
| Latvia | (L01EA01) imatinib (adm: O) | Imatinib Accord | 30 Apvalkotā tablete, 400 mg | Retail price with vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | AccordHealthcareS.L.U.,Spain / AccordHealthcarePolskaSp.z.o.o.,Poland |
| Latvia | (L01EA01) imatinib (adm: O) | Imatinib Teva | 30 Apvalkotā tablete, 400 mg | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Precursor Cell Lymphoblastic Leukemia-Lymphoma;Myelodysplastic-Myeloproliferative Diseases;Hypereosinophilic Syndrome;Dermatofibrosarcoma | TevaB.V.,Netherlands / TevaPharmaceuticalWorksPrivateLimitedCompany,Hungary;TevaUKLtd.,UnitedKingdom;MerckleGmbH,Germany;TEVACzechIndustriess.r.o.,CzechRepublic;TevaPharmaB.V.,Netherlands;TevaOperationsPolandSp.zo.o.,Poland;TevaPharma,S.L.U.,Spain;PlivaCroatiaLtd.,Croatia |
Pages
